Intuitive Surgical, Inc. $ISRG Shares Sold by Orange Investment Advisors Inc.

Orange Investment Advisors Inc. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,312 shares of the medical equipment provider’s stock after selling 909 shares during the period. Intuitive Surgical makes up 3.1% of Orange Investment Advisors Inc.’s holdings, making the stock its 7th biggest holding. Orange Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $29,657,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of ISRG. Tobam boosted its position in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical in the second quarter valued at approximately $27,000. 1248 Management LLC bought a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $30,000. Finally, Riggs Asset Managment Co. Inc. lifted its position in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after acquiring an additional 32 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.1%

Shares of Intuitive Surgical stock opened at $577.81 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a 50 day moving average price of $555.54 and a 200-day moving average price of $507.27. The company has a market cap of $207.13 billion, a PE ratio of 76.43, a price-to-earnings-growth ratio of 5.27 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 104 shares of the stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 22,806 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $570.89, for a total value of $13,019,717.34. Following the completion of the transaction, the insider owned 2,694 shares in the company, valued at $1,537,977.66. The trade was a 89.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on ISRG shares. Daiwa Capital Markets increased their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Jefferies Financial Group raised their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday. UBS Group set a $600.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.